BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37885338)

  • 21. Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with risk of mortality by age.
    Oh CM; Won YJ; Cho H; Lee JK; Park BY; Jun JK; Koh DH; Ki M; Jung KW; Oh IH
    Liver Int; 2016 Jan; 36(1):126-35. PubMed ID: 26036985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
    Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
    Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite associations between alanine aminotransferase and γ-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Williams KH; Sullivan DR; Nicholson GC; George J; Jenkins AJ; Januszewski AS; Gebski VJ; Manning P; Tan YM; Donoghoe MW; Ehnholm C; Young S; O'Brien R; Buizen L; Twigg SM; Keech AC
    Metabolism; 2016 May; 65(5):783-793. PubMed ID: 27085785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
    Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
    PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of new onset of diabetes mellitus during a 10-year period by using a combination of levels of alanine aminotransferase and γ-glutamyl transferase.
    Miyamori D; Tanaka M; Furuhashi M; Ohnishi H; Koyama M; Osanami A; Higashiura Y; Numata K; Hisasue T; Hanawa N; Moniwa N; Miura T
    Endocr J; 2021 Dec; 68(12):1391-1402. PubMed ID: 34234055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study.
    Fujii H; Doi H; Ko T; Fukuma T; Kadono T; Asaeda K; Kobayashi R; Nakano T; Doi T; Nakatsugawa Y; Yamada S; Nishimura T; Tomatsuri N; Sato H; Okuyama Y; Kimura H; Kishimoto E; Nakabe N; Shima T
    BMC Gastroenterol; 2020 Jul; 20(1):217. PubMed ID: 32650722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of serum liver enzyme levels and their changes over time with all-cause and cause-specific mortality in the general population: a large-scale national health screening cohort study.
    Kim KN; Joo J; Sung HK; Kim CH; Kim H; Kwon YJ
    BMJ Open; 2019 Jun; 9(5):e026965. PubMed ID: 31154308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
    Kaneko S; Kurosaki M; Inada K; Kirino S; Hayakawa Y; Yamashita K; Osawa L; Sekiguchi S; Higuchi M; Takaura K; Maeyashiki C; Tamaki N; Yasui Y; Itakura J; Takahashi Y; Tsuchiya K; Nakanishi H; Izumi N
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2943-2951. PubMed ID: 34057248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B.
    Wang J; Xia J; Zhang R; Yan X; Yang Y; Zhao X; Chang H; Wang G; Chen G; Liu Y; Chen Y; Jia B; Zhang Z; Ding W; Huang R; Wu C
    J Viral Hepat; 2018 Oct; 25(10):1151-1160. PubMed ID: 29741221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
    Ju MJ; Qiu SJ; Fan J; Zhou J; Gao Q; Cai MY; Li YW; Tang ZY
    J Gastroenterol; 2009; 44(6):635-42. PubMed ID: 19387533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study.
    Wang XD; Pan CW; Zhou GY; Gao F; Wang FL; Fu RQ; Xiao EH; Li P; Zhang H; Zheng MH
    J Viral Hepat; 2022 Mar; 29(3):196-204. PubMed ID: 34902216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-glutamyl transferase and the risk of all-cause and disease-specific mortality in patients with diabetes: A nationwide cohort study.
    Chung GE; Jeong SM; Yu SJ; Yoo JJ; Cho Y; Lee KN; Shin DW; Kim YJ; Yoon JH; Han K; Cho EJ
    J Diabetes; 2024 May; 16(5):e13551. PubMed ID: 38664890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
    Alshuwaykh O; Daugherty T; Cheung A; Goel A; Dhanasekaran R; Ghaziani TT; Ahmed A; Dronamraju D; Kumari R; Kwong A; Nguyen M; Kim WR; Kwo PY
    Hepatol Commun; 2022 Nov; 6(11):3052-3061. PubMed ID: 36004713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patients via reducing severity and progression of malignancy.
    Wang Y; Xiang X; Chen L; Cao Z; Bao R; Zhou H; Tang W; Lu J; Lin L; Xie Q; Bao S; Wang H
    Oncotarget; 2016 Sep; 7(36):58553-58562. PubMed ID: 27329718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liver histological status and clinic outcome in HBeAg-negative chronic hepatitis B with low viral load].
    Deng DL; Jiang JN; Su MH; Wang RM; Zang WW; Ling XZ; Wei HL; Liang XS; Zhou HK; He WM; Guo RS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):1013-1017. PubMed ID: 34865348
    [No Abstract]   [Full Text] [Related]  

  • 37. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
    Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
    Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q; Li W; Huang Y; Chen L
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum gamma-glutamyltransferase predicts advanced histological liver damage in chronic hepatitis B.
    Yu Y; Fan Y; Yang Z; Lu Y; Xu Q; Chen X
    Discov Med; 2016 Jan; 21(113):7-14. PubMed ID: 26896597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study.
    Wu L; Zhang M; Hu H; Wan Q
    Lipids Health Dis; 2021 Oct; 20(1):142. PubMed ID: 34689770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.